| Dr Robert L Savereide, | |
|
328 W Conan St, Ely, MN 55731-1145 | |
| (218) 365-3271 | |
| Not Available |
| Full Name | Dr Robert L Savereide |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 328 W Conan St, Ely, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477591394 | NPI | - | NPPES |
| 1149419 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 21090 (Iowa) | Primary |
| Entity Name | Ely-bloomenson Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770542904 PECOS PAC ID: 0042200040 Enrollment ID: O20040513000074 |
News Archive
The findings are the first to associate decline in body mass index (BMI) with the eventual onset of AD. The researchers suggest that the loss of body mass reflects disease processes and that change in BMI might be a clinical predictor of the development of AD.
A study by National Institutes of Health scientists in the Office of Disease Prevention examined NIH grants and cooperative agreements during fiscal years 2012 through 2017 to determine the alignment of prevention research across NIH institutes and centers with leading risk factors and causes of death and disability in the United States.
The mechanical resistance of tumors and collateral damage of standard treatments often hinder efforts to defeat cancers.
There is a known link between elevated body mass index (BMI) and symptomatic knee osteoarthritis (OA). While patients who have undergone gastric bypass surgery (GBS)-a procedure that closes off much of the stomach and causes food to bypass a portion of the small intestine─typically lose weight, the comparative impact of this weight loss on knee pain and function has not been measured.
Researchers at Washington University School of Medicine in St. Louis have identified a potent regulator of sensitivity to insulin, the hormone that controls blood sugar levels. The new findings may help scientists find better treatments for type 2 diabetes, obesity and other health problems caused by the body's inability to properly regulate blood sugar.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert L Savereide, 328 W Conan St, Ely, MN 55731-1145 Ph: (218) 365-3271 | Dr Robert L Savereide, 328 W Conan St, Ely, MN 55731-1145 Ph: (218) 365-3271 |
News Archive
The findings are the first to associate decline in body mass index (BMI) with the eventual onset of AD. The researchers suggest that the loss of body mass reflects disease processes and that change in BMI might be a clinical predictor of the development of AD.
A study by National Institutes of Health scientists in the Office of Disease Prevention examined NIH grants and cooperative agreements during fiscal years 2012 through 2017 to determine the alignment of prevention research across NIH institutes and centers with leading risk factors and causes of death and disability in the United States.
The mechanical resistance of tumors and collateral damage of standard treatments often hinder efforts to defeat cancers.
There is a known link between elevated body mass index (BMI) and symptomatic knee osteoarthritis (OA). While patients who have undergone gastric bypass surgery (GBS)-a procedure that closes off much of the stomach and causes food to bypass a portion of the small intestine─typically lose weight, the comparative impact of this weight loss on knee pain and function has not been measured.
Researchers at Washington University School of Medicine in St. Louis have identified a potent regulator of sensitivity to insulin, the hormone that controls blood sugar levels. The new findings may help scientists find better treatments for type 2 diabetes, obesity and other health problems caused by the body's inability to properly regulate blood sugar.
› Verified 7 days ago